UBS analyst Karl Keirstead raised the firm’s price target on VMware (VMW) to $147 from $131 and keeps a Neutral rating on the shares. The analyst contends that conversation with industry sources suggest that the risk of product overlap between VMware and Broadcom (AVGO), and hence the possibility to bundle their offerings in an anti-competitive fashion that would be an issue for regulators, is "over-stated".
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on VMW:
- Broadcom CEO Tan plans to seek more acquisitions after VMware, FT reports
- U.K. antitrust agency opens investigation into Broadcom, VMware deal
- Broadcom loss of Apple socket immaterial for 2-plus years, says BofA
- Piper reveals top cloud automation software picks heading into 2023
- Broadcom’s (NASDAQ:AVGO) $61B VMware Deal Faces EU Antitrust Probe